Wisconsin To Get $4 Million In Multistate Drug Lawsuit

MADISON Wis. – (AP) Attorney General J.B. Van Hollen said Tuesday that Wisconsin will get more than $4 million in a multistate settlement with drug manufacturer AstraZeneca. The drug maker allegedly marketed the anti-psychotic drug Seroquel for uses not approved by federal regulators, including...

AstraZeneca Wins Patent Dispute Over Crestor

NEW YORK - (AP) AstraZeneca Plc said Tuesday it won a patent challenge brought against its blockbuster cholesterol drug Crestor by generic drug developers. The U.S. District Court in Delaware ruled that a key patent on the company's third best-selling drug is valid and that challenger Apotex could...

AstraZeneca Settles Nearly 4,000 Seroquel Injury Claims; Terms Confidential

LONDON - (Mealey's) AstraZeneca PLC said July 29 that it has agreed in principle to settle with nearly 4,000 Seroquel product liability plaintiffs. The company said settlement terms are confidential. In notes to its second-quarter financial report, AstraZeneca said that as of July 27, mediation...

AstraZeneca Agrees To Settle 17,500 Seroquel Cases For $198 Million

WILMINGTON, Del. — AstraZeneca announced Aug. 9 that it has reached agreements in principle to settle about 17,500 Seroquel claims in the United States for about $198 million. “The specific terms of the agreements, which are the result of court-ordered mediation, are confidential,”...

AstraZeneca Pays $198M To Settle Seroquel Lawsuits

LONDON - (AP) AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. Full version available to lexis.com subscriber .

AstraZeneca Pays States $68.5M For Off-Label Marketing Of Seroquel Antipsychotic

TRENTON, N.J. - (Mealey's) AstraZeneca Pharmaceuticals L.P. and AstraZeneca L.P. on March 10 agreed to pay $68.5 million to 37 states and the District of Columbia to resolve allegations in a New Jersey state court lawsuit that it marketed its atypical antipsychotic drug Seroquel for off-label uses...

AstraZeneca Paying $68.5 Million In Seroquel Settlement

WASHINGTON, D.C. - (AP) AstraZeneca will pay $68.5 million as part of a multistate settlement over allegations that the drug developer promoted its blockbuster psychiatric drug Seroquel for insomnia, Alzheimer's and other unapproved uses. The New Jersey Attorney General's Office announced the...

AstraZeneca Settles Patent Litigation With Handa

LONDON - (AP) Drug maker AstraZeneca says it has reached an agreement with a U.S. company to settle patent infringement litigation. AstraZeneca said Friday that Handa Pharmaceuticals of Fremont, California had accepted that AstraZeneca had valid patents for Seroquel XR for the treatment of depression...

N.J. Risperdal Jury Finds Diabetes Warning Lacking, But Drug Didn't Cause Disease

NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the risk of diabetes but that the atypical antipsychotic...

Kentucky Appeals Court Vacates $130 Million Drug-Pricing Verdicts, Says State Was 'Complicit'

FRANKFORT, Ky. - A Kentucky appeals court panel on Oct. 12 vacated verdicts totaling more than $130.7 million against two drug makers for publishing inflated average wholesale prices (AWPs), saying the Kentucky Medicaid program was well aware of the practice and was complicit in the scheme ( Sandoz Inc...

William A. Ruskin: Comcast May Be A Class Action Game-Changer, But Not In Boston

By William A. Ruskin | In Comcast Corp. v Behrend , 133 S.Ct. 1426 (March 27, 2013) [ enhanced opinion available to lexis.com subscribers ], the Supreme Court held that the lower court erred in failing to consider flaws in plaintiffs' damages model merely because the damages model would be pertinent...